narrow-moat cooper report healthi fiscal year
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research dec
estim sep
price data dec
rate updat dec
currenc amount express
methodolog valu compani
compani releas strong fourth-quart full-
year result experienc growth revenu
respect
slightli manag
guidanc line expect also
benefit pronounc oper margin expans
increas full-year margin
basi remain stabl pro forma
basi differ metric larg attribut
relat
acquisit integr activ accordingli may
rais fair valu estim slightli account
expans howev underli view narrow-moat
compani competit advantag moati
contact iud space abl innov
distinguish nich high regulatori barrier
entri remain unchang manag provid
guidanc companywid sale growth
vision segment rang estim roughli higher
project rang surgic segment notabl
manag warn investor expect soft
first quarter due buy-in activ associ
paragard price
increas manufactur
shakeout vision segment
cooper vision segment grew fourth quarter
year continu led robust
growth attract daili silicon hydrogel len
space growth asia-pacif region almost
doubl second fastest grow geograph
segment america grew fourth
quarter notabl receiv fda approv ahead
schedul novemb innov misight product
myopia near-sight manag product
target address issu children
product first kind manag
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
cooper compani oper two unit coopervis coopersurg
account approxim total sale coopervis
second largest player oligopolist contact len market
coopervis sale intern territori second unit
coopersurg develop manufactur diagnost surgic
product gynecologist obstetrician includ paragard iud
acquir teva
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
estim underserv market could worth
multibillion dollar target launch
misight product march target
corpor spend estim million
million manag expect
spend translat roughli million sale
million sale anticip stem
 potenti doubl size year come
howev temper expect cooper
manufactur sever innov product
anticip mitig year howev still expect
constraint persist fiscal year
capac constraint
suffer
surgic segment revenu increas
fourth quarter paragard grow manag
accredit lower-than-averag perform
multi-year averag sell price increas around
addit manag pull televis advertis
product notabl campaign new york citi
metro area comment believ
campaign success translat top-lin momentum
plan focu less costli advertis method
aim smaller dispers market fertil revenu
growth quarter buoy segment led
high ivf consum sale howev still view
segment competit advantag sole relat
paragard product signific differenti
nonhormon iud approv iud
approv longest durat remain optimist
product growth potenti
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end octob
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end octob
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
